Drug intelligence / Profile preview

miR-216a adenovirus

Development stage
Preclinical
Lead developer
Fuwai Hospital
Modality
Gene Therapies
Administration
Intravenous
01

Overview

miR-216a adenovirus is a viral vector-based research tool used to overexpress microRNA-216a (miR-216a) in experimental models. In the context of cardiovascular research, miR-216a has been identified as a pro-inflammatory factor that promotes atherosclerosis progression by inducing M1 macrophage polarization. Mechanistically, miR-216a targets and inhibits the expression of Smad3 and IκBα, which subsequently activates NF-κB-responsive pro-inflammatory genes such as monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor alpha (TNF-α). This adenovirus is primarily utilized as a laboratory reagent to study the molecular pathways of plaque instability, lipid accumulation, and macrophage polarization in ApoE-/- mouse models.

Other names
Ad-miR-216aAd-miR216aAd-miR 216aadenoviral miR-216amicroRNA-216a adenovirusmicroRNA216a adenovirusmicroRNA 216a adenovirus
02

Targets

SMAD3 (SMAD family member 3)Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha (NFKBIA) mRNA

Beyond the preview

Go deeper on miR-216a adenovirus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-216a adenovirus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call